Same activities as rosaglitazone but different formulation. Antidiabetic, hypoglycemic agent. Potent and selective peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist. Potent insulin sensitizing agent binding to the PPAR receptors in fat cells and making the cells more responsive to insulin. Ameliorates insulin resistance. Improves blood pressure and vascular function. Enhances proliferation of endogenous neural progenitor cells (NPCs). Anti-inflammatory compound. Has controversial therapeutic effects on the cardiovascular system. Promotes adipocyte differentiation of mesenchymal stem cells (MSCs). CAS Number: 155141-29-0 Alternative Names: BRL 49653C, Rosiglitazone XR, Avandia Molecular Formula: C18H19N3O3S . C4H4O4 Solubility: Soluble in ethanol or buffered aqueous solutions with pH 2.3 Molecular Weight: ~357.4, 116.1 Method for Determining Identity: Proton NMR and Infrared Spectroscopy Appearance: Supplied as a white to off-white powder. Purity: 98% (NMR) Storage and Stability: Store at 4C. Stable for 12 months after receipt, when stored at 4C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molekulargewicht:
357.41161
Reinheit:
98% (NMR)
Formulierung:
Supplied as a white to off-white powder.
CAS Nummer:
[155141-29-0]
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
